Correlation Between Taigen Biopharmaceutica and Pan International

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Taigen Biopharmaceutica and Pan International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Taigen Biopharmaceutica and Pan International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Taigen Biopharmaceuticals Holdings and Pan International Industrial Corp, you can compare the effects of market volatilities on Taigen Biopharmaceutica and Pan International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Taigen Biopharmaceutica with a short position of Pan International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Taigen Biopharmaceutica and Pan International.

Diversification Opportunities for Taigen Biopharmaceutica and Pan International

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Taigen and Pan is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Taigen Biopharmaceuticals Hold and Pan International Industrial C in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pan International and Taigen Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Taigen Biopharmaceuticals Holdings are associated (or correlated) with Pan International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pan International has no effect on the direction of Taigen Biopharmaceutica i.e., Taigen Biopharmaceutica and Pan International go up and down completely randomly.

Pair Corralation between Taigen Biopharmaceutica and Pan International

Assuming the 90 days trading horizon Taigen Biopharmaceuticals Holdings is expected to under-perform the Pan International. But the stock apears to be less risky and, when comparing its historical volatility, Taigen Biopharmaceuticals Holdings is 1.01 times less risky than Pan International. The stock trades about -0.01 of its potential returns per unit of risk. The Pan International Industrial Corp is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  4,075  in Pan International Industrial Corp on August 27, 2024 and sell it today you would lose (160.00) from holding Pan International Industrial Corp or give up 3.93% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Taigen Biopharmaceuticals Hold  vs.  Pan International Industrial C

 Performance 
       Timeline  
Taigen Biopharmaceutica 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Taigen Biopharmaceuticals Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Pan International 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Pan International Industrial Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Pan International may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Taigen Biopharmaceutica and Pan International Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Taigen Biopharmaceutica and Pan International

The main advantage of trading using opposite Taigen Biopharmaceutica and Pan International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Taigen Biopharmaceutica position performs unexpectedly, Pan International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pan International will offset losses from the drop in Pan International's long position.
The idea behind Taigen Biopharmaceuticals Holdings and Pan International Industrial Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios